ZANZALINTINIB: 36 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
36
Total FAERS Reports
3 (8.3%)
Deaths Reported
33
Hospitalizations
36
As Primary/Secondary Suspect
4
Life-Threatening
First Report: 20230308 · Latest Report: 20240413
What Are the Most Common ZANZALINTINIB Side Effects?
#1 Most Reported
Pyrexia
9 reports (25.0%)
#2 Most Reported
Hyponatraemia
5 reports (13.9%)
#3 Most Reported
Urinary tract infection
4 reports (11.1%)
All ZANZALINTINIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 9 | 25.0% | 1 | 9 |
| Hyponatraemia | 5 | 13.9% | 0 | 4 |
Who Reports ZANZALINTINIB Side Effects? Age & Gender Data
Gender: 44.1% female, 55.9% male. Average age: 57.2 years. Most reports from: KR. View detailed demographics →
Is ZANZALINTINIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2023 | 32 | 3 | 30 |
| 2024 | 4 | 0 | 3 |
What Is ZANZALINTINIB Used For?
| Indication | Reports |
|---|---|
| Colorectal cancer metastatic | 19 |
| Colorectal cancer | 12 |
Official FDA Label for ZANZALINTINIB
Official prescribing information from the FDA-approved drug label.